You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSRI (paroxetine)

Showing 1 - 25 of 487
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Opioid Induced Respiratory Depression, Depressive Disorder, Anxiety Disorders Trial (Oxycodone Hydrochloride, Placebo)

Not yet recruiting
  • Opioid Induced Respiratory Depression
  • +2 more
  • Oxycodone Hydrochloride
  • Placebo
  • (no location specified)
Feb 14, 2023

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

Not yet recruiting
  • Hypercapnia
  • Ventilatory Depression
  • Placebo and Oxycodone
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jul 20, 2022

The Antidepressant Advisor: fMRI Study to Predict Treatment

Completed
  • Major Depressive Disorder
    • London, United Kingdom
      King's College London, IoPPN
    Jan 4, 2023

    15 Different Antidepressants in Major Depressive Disorder

    Completed
    • Major Depressive Disorder
    • Copenhagen, Denmark
      Psychiatric Center Copenhagen
    Jul 18, 2023

    Depression Trial (Fecal microbiota transplantation(FMT), Placebo)

    Not yet recruiting
    • Depression
    • Fecal microbiota transplantation(FMT)
    • Placebo
    • (no location specified)
    May 6, 2023

    MDD Trial in Hangzhou (SSRI, SIA, AIA)

    Recruiting
    • Major Depressive Disorder
    • Hangzhou, Zhejiang, China
      the Third affiliated hospital of Zhejiang Chinese Medical univer
    Apr 15, 2023

    MDD Trial in Shanghai (SSRIs, SSRI plus Sulforaphane)

    Recruiting
    • Major Depressive Disorder
    • SSRIs
    • SSRI plus Sulforaphane
    • Shanghai, China
      Shanghai Mental Health Center
    Dec 6, 2021

    OCD, EEG With Periodic Abnormalities Trial in Istanbul (Deep Transcranial Magnetic Stimulation, Paroxetine)

    Active, not recruiting
    • Obsessive-Compulsive Disorder
    • EEG With Periodic Abnormalities
    • Istanbul, Beykoz, Turkey
      Istanbul Medipol University
    Dec 26, 2021

    Healthy Trial in Basel (Paroxetine, Lysergic Acid Diethylamide, Placebo)

    Not yet recruiting
    • Healthy
    • Basel, Switzerland
      Clinical Pharmacology & Toxicology, University Hospital Basel
    Dec 14, 2021

    PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written

    Recruiting
    • PTSD
    • Selective serotonin reuptake inhibitor
    • +2 more
    • North Little Rock, Arkansas
    • +15 more
    Aug 2, 2022

    Anxiety Disorder, OCD Trial in Changsha (Paroxetine)

    Recruiting
    • Anxiety Disorder
    • Obsessive-Compulsive Disorder
    • Changsha, China
      The Second Xiangya Hospital of Central South University
    Feb 1, 2021

    MDD Trial (Vortioxetine, Sertraline, citalopram)

    Active, not recruiting
    • Major Depressive Disorder
    • Catanzaro, Italy
    • +2 more
    Oct 7, 2022

    MDD Trial in San Francisco (Standard Clinical Care with an SRRI)

    Recruiting
    • Major Depressive Disorder
    • Standard Clinical Care with an SRRI
    • San Francisco, California
      University of California San Francisco
    Mar 2, 2022

    Rheumatoid Arthritis Trial in Shibin Al Kawm (Paroxetine, Placebo)

    Recruiting
    • Rheumatoid Arthritis
    • Shibīn Al Kawm, Menoufia, Egypt
      Faculty of Pharmacy
    Jan 16, 2023

    Anxiety Disorders Trial (Paroxetine)

    Not yet recruiting
    • Anxiety Disorders
    • (no location specified)
    Sep 26, 2023

    MDD Trial in Hangzhou (SSRI, SIA, AIA)

    Recruiting
    • Major Depressive Disorder
    • Hangzhou, Zhejiang, China
      the Third affiliated hospital of Zhejiang Chinese Medical univer
    Jan 31, 2023

    Vasomotor Symptoms Trial (oxybutynin ER, Paroxetine CR)

    Not yet recruiting
    • Vasomotor Symptoms
    • oxybutynin ER
    • Paroxetine CR
    • (no location specified)
    Dec 1, 2022

    Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)

    Not yet recruiting
    • Healthy
    • DA-8010 5mg
    • +2 more
    • Soeul, Korea, Republic of
      Seoul National University Hospital
    Aug 7, 2023

    Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

    Completed
    Has Results
    • Depressive Disorder, Major
    • Phoenix, Arizona
    • +49 more
    Jul 20, 2022

    MDD Co-Occurrent With Anxiety, Adult Patients, Newly Diagnosed Depression Trial in Czechia

    Recruiting
    • Major Depressive Disorder Co-Occurrent With Anxiety
    • +2 more
      • Brno, Czechia
      • +5 more
      Jan 31, 2023

      MDD Trial in Manchester, Liverpool (SPL026)

      Recruiting
      • Major Depressive Disorder
      • Manchester, Greater Manchester, United Kingdom
      • +1 more
      Jan 18, 2023

      Uremic Pruritis Trial in Alexandria (sertraline, )

      Completed
      • Uremic Pruritis
      • Alexandria, Egypt
        Faculty of Medicine, Aexandria University
      Dec 12, 2022

      Cardiac Remodeling, Myocardial Infarction Trial in Bern (Paroxetine, Placebo oral capsule)

      Completed
      • Cardiac Remodeling
      • Myocardial Infarction
      • Bern, Switzerland
        Bern University Hospital, Department of Cardiology
      May 29, 2022